Fredun Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194R01017
  • NSEID:
  • BSEID: 539730
INR
2,249.55
-73.65 (-3.17%)
BSENSE

Jun 11, 03:30 PM

BSE+NSE Vol: 9.54 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002605,
    "name": "Fredun Pharma",
    "stock_name": "Fredun Pharma",
    "full_name": "Fredun Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/fredun-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,249.55",
    "chg": -73.65,
    "chgp": "-3.17%",
    "dir": -1,
    "prev_price": "2,323.20",
    "mcapval": "1,286.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539730,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE194R01017",
    "curr_date": "Jun 11, 03:30 PM",
    "curr_time": "02:48 AM",
    "last_traded_at": "Jun 11, 03:30 PM IST",
    "bse_nse_vol": "9.54 k",
    "exc_status": "Active",
    "traded_date": "Jun 11, 2026",
    "traded_date_str": "2026 06 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Fredun Pharmaceuticals Upgraded to Buy on Strong Financial and Valuation Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-upgraded-to-buy-on-strong-financial-and-valuation-metrics-4025596",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FredunPharmaceu_mojoScore_4025596.png",
        "date": "2026-06-01 08:23:19",
        "description": "Fredun Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its financial performance, valuation metrics, quality indicators, and technical outlook. The micro-cap pharmaceutical company’s recent quarterly results, improved valuation multiples, and sustained operational momentum have collectively driven this positive revision in its investment grade."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Declines 1.32% Despite Strong Financials and Valuation Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-declines-132-despite-strong-financials-and-valuation-shift-4022877",
        "imagepath": "",
        "date": "2026-05-30 13:03:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>25 May:</strong> New 52-week and all-time high reached at Rs.2,620</p>\n                    <p><strong>26 May:</strong> Strong quarterly results reported amid margin pressures</p>\n                    <p><strong>27 May:</strong> Valuation shift noted, enhancing price attractiveness</p>\n                    <p><strong>29 May:</strong> Stock rebounds with a 5.27% gain despite Sensex decline</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,528.85</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-va..."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-hold-4017898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_mojoScore_4017898.png",
        "date": "2026-05-28 10:10:30",
        "description": "Fredun Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 May 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd: Valuation Shift Enhances Price Attractiveness Amid Robust Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-valuation-shift-enhances-price-attractiveness-amid-robust-returns-4015644",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_valuationdot_4015644.png",
        "date": "2026-05-27 08:01:41",
        "description": "Fredun Pharmaceuticals Ltd has undergone a notable shift in its valuation parameters, moving from an expensive to an attractive price range. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positions the micro-cap pharmaceutical company as a compelling consideration within its sector amid robust returns and improving fundamentals."
      },
      {
        "title": "Fredun Pharmaceuticals Reports Strong Quarterly Gains Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-reports-strong-quarterly-gains-amid-margin-pressures-4012315",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_fintrenddot_4012315.png",
        "date": "2026-05-26 08:00:15",
        "description": "Fredun Pharmaceuticals Ltd has delivered its highest quarterly revenue and profit figures in the March 2026 quarter, signalling robust top-line growth despite emerging margin pressures and increased interest costs. The company’s financial trend has moderated from very positive to positive, reflecting a nuanced performance that investors should carefully analyse amid a recent downgrade in its Mojo Grade to Hold."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2620",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2620-4010559",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_priceRelatedfactors_4010559.png",
        "date": "2026-05-25 10:48:41",
        "description": "Surging past its previous peaks, Fredun Pharmaceuticals Ltd touched a new 52-week high of Rs 2620 on 25 May 2026, marking a remarkable 253.81% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained earnings growth, setting the stage for a compelling price rally within the pharmaceuticals sector."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 2,620 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-all-time-high-at-rs-2620-mark-4010483",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_priceRelatedfactors_4010483.png",
        "date": "2026-05-25 10:29:42",
        "description": ""
      },
      {
        "title": "Fredun Pharmaceuticals Gains 6.86%: Four Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-gains-686-four-key-factors-driving-the-surge-4008259",
        "imagepath": "",
        "date": "2026-05-23 13:06:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Stock opens at Rs.2,302.55, down 2.70%</p>\n                    <p><strong>21 May:</strong> New 52-week and all-time high at Rs.2,560</p>\n                    <p><strong>22 May:</strong> Hits record high of Rs.2,619.95</p>\n                    <p><strong>22 May:</strong> Week closes at Rs.2,528.85, up 6.86%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,366.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,528.85</div><div class=\"stat-change positive\">+6.86%</di..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2619.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-new-52-week-high-of-rs261995-4004666",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_priceRelatedfactors_4004666.png",
        "date": "2026-05-22 09:47:36",
        "description": "Surging past its previous peaks, Fredun Pharmaceuticals Ltd reached a new 52-week high of Rs 2619.95 on 22 May 2026, marking a remarkable rally that has seen the stock gain over 250% in the past year. This milestone reflects a powerful confluence of technical momentum and sustained price strength, setting the stage for further market attention."
      }
    ],
    "total": 276,
    "sid": "1002605",
    "stock_news_url": "https://www.marketsmojo.com/news/fredun-pharmaceuticals-1002605"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "10-Jun-2026",
      "details": "Audio Recording of the Q4 and year ended for the FY26 Earnings Conference Call",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Jun-2026",
      "details": "Newspaper Clipping- Information regarding 39th Annual General Meeting to be held on 30th June 2026 through video conference/other audio visual means.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).",
      "datetime": "08-Jun-2026",
      "details": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Fredun Pharmaceuticals Ltd has declared <strong>7%</strong> dividend, ex-date: 23 Jun 26",
          "dt": "2026-06-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Fredun Pharmaceuticals Ltd Declines 1.32% Despite Strong Financials and Valuation Shift

2026-05-30 13:03:11

Key Events This Week

25 May: New 52-week and all-time high reached at Rs.2,620

26 May: Strong quarterly results reported amid margin pressures

27 May: Valuation shift noted, enhancing price attractiveness

29 May: Stock rebounds with a 5.27% gain despite Sensex decline

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

10-Jun-2026 | Source : BSE

Audio Recording of the Q4 and year ended for the FY26 Earnings Conference Call

Announcement under Regulation 30 (LODR)-Newspaper Publication

09-Jun-2026 | Source : BSE

Newspaper Clipping- Information regarding 39th Annual General Meeting to be held on 30th June 2026 through video conference/other audio visual means.

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).

08-Jun-2026 | Source : BSE

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Fredun Pharmaceuticals Ltd has declared 7% dividend, ex-date: 23 Jun 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available